A Phase II, Multi-center, Single Arm, Open Label Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma

Name: A Phase II, Multi-center, Single Arm, Open Label Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma
Creator: Vivli
Published: 2026-03-27 13:34:51
License: 暂无描述

DataCite Commons2026-03-27 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00012926/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

This study is designed to assess the effectiveness of the combination of Panobinostat plus Bortezomib and Dexamethasone in patients with relapsed and bortezomib refractory Multiple Myeloma.

提供机构：

Vivli

创建时间：

2026-03-27